Literature DB >> 29929376

Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.

Ondrej Bezdicek1,2, Markéta Červenková1,2, Tyler M Moore3, Hana Stepankova Georgi2, Zdenek Sulc2, David A Wolk3, Daniel A Weintraub3,4,5, Paul J Moberg3, Robert Jech1, Miloslav Kopecek1,2, David R Roalf3.   

Abstract

The Montreal Cognitive Assessment (MoCA) is one of the most common screening instruments for mild cognitive impairment. However, the standard MoCA is approximately two times longer to administer than the Mini-Mental State Examination. A total of 699 Czech and 175 American participants received the standard MoCA Czech and English versions and in the clinical part, a sample of 102 nondemented patients with Parkinson's disease (PD). We created a validated Czech short version (s-MoCA-CZ) from the original using item response theory. As expected, s-MoCA-CZ scores were highly correlated with the standard version (Pearson r = .94, p < .001). s-MoCA-CZ also had 80% classification accuracy in the differentiation of PD mild cognitive impairment from PD without impairment. The s-MoCA-CZ, a brief screening tool, is shorter to administer than the standard MoCA. It provides high-classification accuracy for PD mild cognitive impairment and is equivalent to that of the standard MoCA-CZ.

Entities:  

Keywords:  MMSE; MoCA; cognitive screening; s-MoCA; s-MoCA-CZ; test equating

Mesh:

Year:  2018        PMID: 29929376      PMCID: PMC6274600          DOI: 10.1177/1073191118778896

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  47 in total

1.  A basis for analyzing test-retest reliability.

Authors:  L GUTTMAN
Journal:  Psychometrika       Date:  1945       Impact factor: 2.500

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  A comparison of normative data for the Trail Making Test from several countries: equivalence of norms and considerations for interpretation.

Authors:  Alberto L Fernández; Bernice A Marcopulos
Journal:  Scand J Psychol       Date:  2008-06

4.  Development of an abbreviated form of the Penn Line Orientation Test using large samples and computerized adaptive test simulation.

Authors:  Tyler M Moore; J Cobb Scott; Steven P Reise; Allison M Port; Chad T Jackson; Kosha Ruparel; Adam P Savitt; Raquel E Gur; Ruben C Gur
Journal:  Psychol Assess       Date:  2015-03-30

5.  The economic impact of cognitive impairment in Parkinson's disease.

Authors:  Corinna Vossius; Jan P Larsen; Carmen Janvin; Dag Aarsland
Journal:  Mov Disord       Date:  2011-04-29       Impact factor: 10.338

6.  Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

Authors:  E R Dorsey; R Constantinescu; J P Thompson; K M Biglan; R G Holloway; K Kieburtz; F J Marshall; B M Ravina; G Schifitto; A Siderowf; C M Tanner
Journal:  Neurology       Date:  2006-11-02       Impact factor: 9.910

7.  Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.

Authors:  Sarra Nazem; Andrew D Siderowf; John E Duda; Tom Ten Have; Amy Colcher; Stacy S Horn; Paul J Moberg; Jayne R Wilkinson; Howard I Hurtig; Matthew B Stern; Daniel Weintraub
Journal:  J Am Geriatr Soc       Date:  2008-12-10       Impact factor: 5.562

8.  Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Authors:  S Hoops; S Nazem; A D Siderowf; J E Duda; S X Xie; M B Stern; D Weintraub
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

9.  A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.

Authors:  Cindy Zadikoff; Susan H Fox; David F Tang-Wai; Teri Thomsen; Rob M A de Bie; Pettarusup Wadia; Janis Miyasaki; Sarah Duff-Canning; Anthony E Lang; Connie Marras
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

10.  Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.

Authors:  Sophie Fengler; Josef Kessler; Lars Timmermann; Alexandra Zapf; Saskia Elben; Lars Wojtecki; Oliver Tucha; Elke Kalbe
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

View more
  4 in total

1.  A 4-Item Case-Finding Tool to Detect Dementia in Older Persons.

Authors:  Tau Ming Liew
Journal:  J Am Med Dir Assoc       Date:  2019-08-07       Impact factor: 4.669

2.  The Optimal Short Version of Montreal Cognitive Assessment in Diagnosing Mild Cognitive Impairment and Dementia.

Authors:  Tau Ming Liew
Journal:  J Am Med Dir Assoc       Date:  2019-03-23       Impact factor: 4.669

3.  When CAT is not an option: complementary methods of test abbreviation for neurocognitive batteries.

Authors:  Tyler M Moore; Ellyn R Butler; J Cobb Scott; Allison M Port; Kosha Ruparel; Lucky J Njokweni; Raquel E Gur; Ruben C Gur
Journal:  Cogn Neuropsychiatry       Date:  2020-12-11       Impact factor: 1.871

4.  A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease.

Authors:  Ya-Wen Yu; Chun-Hsiang Tan; Hui-Chen Su; Chung-Yao Chien; Pi-Shan Sung; Tien-Yu Lin; Tsung-Lin Lee; Rwei-Ling Yu
Journal:  Front Aging Neurosci       Date:  2022-06-16       Impact factor: 5.702

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.